Evidence map›Paper›PMID 31599065›Full record

ArticleAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons2020

Modest rates and wide variation in timely access to repeat kidney transplantation in the United States.

Jesse D Schold, Joshua J Augustine, Anne M Huml, John O'Toole, John R Sedor, Emilio D Poggio

Open access · hybridAbstract read
In one paragraph

Article in American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Racial and immunologic disparities impact access to kidney rewaitlisting and retransplantation.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Association Between Transplant Center Continuity and Access to a Second Kidney Transplant in Patients With Allograft Failure.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2024
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Effects of body mass index on kidney transplant outcomes are significantly modified by patient characteristics.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Jesse D ScholdDepartment of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio.ORCID 0000-0002-5341-7286
Joshua J AugustineGlickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio.
Anne M HumlGlickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio.
John O'TooleGlickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio.
John R SedorGlickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio.
Emilio D PoggioGlickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio.
Cleveland Clinic · US

Funding

Barriers to Care for Patients Transitioning from Transplant to DialysisK23DK101492 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI HUML, ANNE MARIE · 2016 to 2020
$800k
NIDDK NIH HHS K23 DK101492
6 · The paper itself

Abstract

Success of transplantation is not limited to initial receipt of a donor organ. Many kidney transplant recipients experience graft loss following initial transplantation and the benefits of expedited placement on the waiting list and retransplantation extend to this population. Factors associated with access to repeat transplantation may be unique given experience with the transplant process and prior viability as a candidate. We examined the incidence, risk factors, secular changes, and center-level variation of preemptive relisting or transplantation (PRLT) for kidney transplant recipients in the United States with graft failure (not due to death) using Scientific Registry of Transplant Recipients data from 2007 to 2018 (n = 39 557). Overall incidence of PRLT was 15% and rates of relisting declined over time. Significantly lower PRLT was evident among patients who were African American and Hispanic, males, older, obese, publicly insured, had lower educational attainment, were diabetic, had longer dialysis time prior to initial transplant, shorter graft survival, longer distance to transplant center, and resided in distressed communities. There was significant variation in PRLT by center, median = 13%, 10th percentile = 6%, 90th percentile = 24%. Cumulatively, results indicate that despite prior access to transplantation, incidence of PRLT is modest with pronounced clinical, social, and center-level sources of variation suggesting opportunities to improve preemptive care among patients with failing grafts.

Indexed as

Kidney TransplantationGraft SurvivalHumansMaleRegistriesRenal DialysisTransplant RecipientsUnited StatesWaiting Listsclinical research/practiceepidemiologyethnicity/racegenderhealth services and outcomes researchkidney failure/injurykidney transplantation/nephrologyretransplantation

Identifiers

PMID31599065
PMCPMC7204603
OpenAlexW2980186036

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.